4.7 Article

Deeply Infiltrating iRGD-Graphene Oxide for the Intensive Treatment of Metastatic Tumors through PTT-Mediated Chemosensitization and Strengthened Integrin Targeting-Based Antimigration

期刊

ADVANCED HEALTHCARE MATERIALS
卷 10, 期 16, 页码 -

出版社

WILEY
DOI: 10.1002/adhm.202100536

关键词

cytoskeleton remodeling-meditated antimigration; deep penetration; graphene oxide; photothermal-chemotherapy; solid tumors

资金

  1. National Natural Science Foundation of China [81703442, 81972835]
  2. National Science and Technology Major Project [2019ZX09301134, 2017ZX09101001]
  3. Fundamental Research Funds for the Central Universities [2632019ZD06]
  4. Double First-rate construction project of China Pharmaceutical University: Advanced Technology in New Drug Discovery and its Inversion and Application [CPU2018GY26]
  5. National Key Research and Development Program of China [2017YFD0501403]
  6. Qing Lan Project of Jiangsu Province

向作者/读者索取更多资源

The study demonstrated the potential of iRGD-modified graphene oxide (IPHG) nanosheets for targeted delivery to treat metastatic tumors, enhancing chemotherapeutic effects and suppressing tumor metastasis through photothermal therapy. This tailored design provides a promising paradigm for combating tumor resistance and metastasis.
A limited infiltration and the subsequent low effective drug concentration result in poor chemotherapeutic outcomes against tumors, and even further promote tumor resistance and metastatic. Herein, iRGD-modified graphene oxide (GO) nanosheets (IPHG) are developed for the intensive treatment of metastatic tumors using focus-specific penetrated delivery together with photothermal therapy-mediated chemosensitization and photothermal therapy-strengthened integrin targeting-based antimigration. In vitro and in vivo data verified the mechanism of the tumor-selective infiltration of IPHG is based on a rigid 2D structure-associated advantage regarding hemodynamics and endothelial contact, followed by iRGD-endowed transendothelial and intratumoral transport. Once IPHG-DOX-penetrated 4T1 tumors are exposed to near-infrared irradiation, hyperthermia stress and photothermal therapy-elevated effective drug concentrations result in chemosensitization and prominent tumor suppression. Meanwhile, the specific binding of iRGD to integrins and photothermal therapy leads to the synergistic perturbation of cytoskeleton remodeling and subsequent impairment of cell motility and metastasis. The tailored design of IPHG validates a promising paradigm for drug delivery to combat tumor resistance and metastasis resulting from poor target access for single chemotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据